Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05977049 · ClinicalTrials.gov registry record · NA
Psychosocial Support for Patients With Takotsubo Syndrome
A NA study of Takotsubo Cardiomyopathy, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05977049: Recruiting NA study of Takotsubo Cardiomyopathy, sponsored by Weill Medical College of Cornell University.
NCT05977049 is a NA study of Takotsubo Cardiomyopathy that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants, below the 522-participant average among 3 other Takotsubo Cardiomyopathy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05977049, a NA study of Takotsubo Cardiomyopathy, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The study hypothesis is that participants enrolled in a virtual Takotsubo support group will have significantly less anxiety at one year.
Primary Outcome
State Trait Anxiety Inventory (STAI): Score of 20-39 = Low Anxiety; Score of 40-59 = Moderate Anxiety; Score of 60 - 80 = High Anxiety
Conditions Studied
Interventions
- BEHAVIORAL Takotsubo Support Group
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-04-17 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05977049 shows while recruiting
NCT05977049 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 522-participant average among 3 other Takotsubo Cardiomyopathy trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Takotsubo Cardiomyopathy appearing as the primary indexed condition, and to 1 intervention - of which Takotsubo Support Group is the first listed.
NCT05977049 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05977049 about?
NCT05977049 is a clinical study titled "Psychosocial Support for Patients With Takotsubo Syndrome". The study hypothesis is that participants enrolled in a virtual Takotsubo support group will have significantly less anxiety at one year.
What is the current status of trial NCT05977049?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-04-17. Estimated completion is 2026-12-31.
What conditions does trial NCT05977049 study?
This clinical trial studies the following conditions: Takotsubo Cardiomyopathy.
What interventions are being tested in trial NCT05977049?
The interventions under investigation include: Takotsubo Support Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05977049?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05977049 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Takotsubo Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI